CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...

CVS Health just rocked the market with a nearly 11% surge in pre-market trading after its Q3 revenue topped expectations, ...

CVS Health Corp (CVS) reports robust growth in retail pharmacy and health services, while navigating challenges in its health ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

(Reuters) - CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

Among the gains in the contract are the elimination of two-tier wage scale and an increased health care bonus.

A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy stalwart ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

The move is one of the first from the new CEO, David Joyner, as he looks to repair the company.